CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a significant growth in short interest in the month of June. As of June 30th, there was short interest totalling 14,900 shares, a growth of 23.1% from the June 15th total of 12,100 shares. Based on an average daily volume of 28,800 shares, the short-interest ratio is currently 0.5 days.
CSPC Pharmaceutical Group Stock Down 0.6 %
Shares of CSPCY stock traded down C$0.02 during mid-day trading on Friday, reaching C$3.10. The stock had a trading volume of 14,921 shares, compared to its average volume of 24,051. The business’s fifty day moving average is C$3.31 and its 200-day moving average is C$3.20. CSPC Pharmaceutical Group has a 1-year low of C$2.63 and a 1-year high of C$3.71.
CSPC Pharmaceutical Group Increases Dividend
The company also recently disclosed a dividend, which was paid on Thursday, July 11th. Stockholders of record on Monday, June 3rd were issued a $0.0573 dividend. The ex-dividend date of this dividend was Friday, May 31st. This is a positive change from CSPC Pharmaceutical Group’s previous dividend of $0.06.
CSPC Pharmaceutical Group Company Profile
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- CD Calculator: Certificate of Deposit Calculator
- Top 3 Defense Stocks That Should Be on Your Radar
- Breakout Stocks: What They Are and How to Identify Them
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.